Marco L Davila Selected Research

Residual Neoplasm

3/2013	CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia.
11/2011	Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marco L Davila Research Topics

Disease

31	Neoplasms (Cancer) 12/2023 - 11/2011
12	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023 - 01/2020
10	Cytokine Release Syndrome 01/2023 - 02/2014
10	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021 - 11/2011
8	Hematologic Neoplasms (Hematological Malignancy) 04/2023 - 04/2014
7	Lymphoma (Lymphomas) 01/2023 - 02/2017
4	Leukemia 01/2020 - 04/2014
4	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2018 - 11/2011
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2023 - 01/2021
3	Cytopenia 01/2023 - 01/2021
3	Infections 12/2022 - 12/2018
3	Graft vs Host Disease (Graft-Versus-Host Disease) 11/2022 - 01/2020
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2024 - 12/2019
2	Inflammation (Inflammations) 04/2023 - 01/2023
2	Multiple Myeloma 03/2023 - 12/2022
2	cell-associated neurotoxicity 01/2021 - 12/2020
2	Philadelphia Chromosome 01/2018 - 02/2014
2	Residual Neoplasm 03/2013 - 11/2011
1	Cardiotoxicity 04/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2023
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 03/2023
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2023
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2023
1	Bronchiolitis Obliterans Syndrome 11/2022
1	Bites and Stings (Sting) 03/2022
1	Pleural Effusion (Pleural Effusions) 01/2021
1	Disease Progression 01/2021
1	Abdominal Pain (Pain, Abdominal) 12/2019
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 07/2016
1	B-Cell Leukemia (Leukemia, B Cell) 11/2011
1	Lymphadenopathy 11/2011

Drug/Important Bio-Agent (IBA)

31	Chimeric Antigen ReceptorsIBA 01/2024 - 04/2013
9	axicabtagene ciloleucelIBA 01/2023 - 12/2019
5	CytokinesIBA 04/2023 - 03/2013
2	Interleukin-6 (Interleukin 6)IBA 04/2023 - 01/2021
2	LigandsIBA 03/2023 - 01/2021
2	tocilizumab (atlizumab)FDA Link 01/2023 - 01/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 01/2021
2	tisagenlecleucelIBA 01/2023 - 01/2021
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022 - 02/2017
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 02/2014
2	AntigensIBA 03/2015 - 11/2011
2	CD19 AntigensIBA 04/2014 - 02/2014
1	Proteins (Proteins, Gene)FDA Link 01/2024
1	CreatinineIBA 04/2023
1	Biomarkers (Surrogate Marker)IBA 04/2023
1	Troponin IIBA 04/2023
1	Interleukin-15 (Interleukin 15)IBA 04/2023
1	NK Cell Lectin-Like Receptor Subfamily KIBA 03/2023
1	Zoledronic Acid (Zometa)FDA Link 01/2023
1	Peptidoglycan (Murein)IBA 01/2023
1	CD83 AntigenIBA 01/2023
1	Interleukin-2 (IL2)IBA 01/2023
1	idecabtagene vicleucelIBA 12/2022
1	ofatumumab FDA Link 11/2022
1	GlucocorticoidsIBA 11/2022
1	Prednisone (Sone)FDA LinkGeneric 11/2022
1	2-toluenesulfonamide (OTS)IBA 03/2022
1	Death Domain ReceptorsIBA 01/2022
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 01/2022
1	Indomethacin (Indometacin)FDA LinkGeneric 01/2022
1	TNF-Related Apoptosis-Inducing LigandIBA 01/2022
1	Ferritins (Ferritin)IBA 01/2021
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2021
1	InterferonsIBA 01/2021
1	Interferon-gamma (Interferon, gamma)IBA 01/2021
1	SteroidsIBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2021
1	Calcineurin InhibitorsIBA 01/2020
1	CatecholaminesIBA 12/2018
1	alpha-Methyltyrosine (Metirosine)FDA Link 12/2018
1	AntibodiesIBA 12/2018
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 02/2014
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2011

Therapy/Procedure

32	Therapeutics 01/2024 - 01/2013
10	Drug Therapy (Chemotherapy) 01/2022 - 11/2011
9	Immunotherapy 04/2023 - 03/2015
3	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2022 - 03/2015
3	Hematopoietic Stem Cell Transplantation 01/2021 - 03/2013
1	Length of Stay 01/2021
1	Salvage Therapy 01/2021
1	Cell Transplantation 01/2020
1	Radiotherapy 12/2019
1	Drug Tapering 12/2019
1	Traction 11/2015